Agile Therapeutics Statistics
Total Valuation
AGRX has a market cap or net worth of $9.67 million. The enterprise value is $7.43 million.
| Market Cap | 9.67M |
| Enterprise Value | 7.43M |
Important Dates
The last earnings date was Thursday, May 9, 2024, after market close.
| Earnings Date | May 9, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
AGRX has 6.86 million shares outstanding. The number of shares has increased by 407.86% in one year.
| Shares Outstanding | 6.86M |
| Shares Change (YoY) | +407.86% |
| Shares Change (QoQ) | +56.29% |
| Owned by Insiders (%) | 0.22% |
| Owned by Institutions (%) | 0.03% |
| Float | 6.85M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 0.96 |
| PS Ratio | 0.45 |
| Forward PS | 0.44 |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.35 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.56
| Current Ratio | 0.56 |
| Quick Ratio | 0.35 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -35.27 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -61.81% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | $1.13M |
| Profits Per Employee | -$410,211 |
| Employee Count | 19 |
| Asset Turnover | 1.86 |
| Inventory Turnover | 2.90 |
Taxes
In the past 12 months, AGRX has paid $764,000 in taxes.
| Income Tax | 764,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -53.47% in the last 52 weeks. The beta is 1.22, so AGRX's price volatility has been higher than the market average.
| Beta (5Y) | 1.22 |
| 52-Week Price Change | -53.47% |
| 50-Day Moving Average | 0.48 |
| 200-Day Moving Average | 1.23 |
| Relative Strength Index (RSI) | 91.47 |
| Average Volume (20 Days) | 325,006 |
Short Selling Information
The latest short interest is 222,097, so 3.24% of the outstanding shares have been sold short.
| Short Interest | 222,097 |
| Short Previous Month | 213,078 |
| Short % of Shares Out | 3.24% |
| Short % of Float | 3.24% |
| Short Ratio (days to cover) | 0.28 |
Income Statement
In the last 12 months, AGRX had revenue of $21.50 million and -$7.79 million in losses. Loss per share was -$3.65.
| Revenue | 21.50M |
| Gross Profit | 12.84M |
| Operating Income | -15.94M |
| Pretax Income | -7.79M |
| Net Income | -7.79M |
| EBITDA | -15.58M |
| EBIT | -15.98M |
| Loss Per Share | -$3.65 |
Balance Sheet
The company has $2.62 million in cash and $378,000 in debt, giving a net cash position of $2.24 million or $0.33 per share.
| Cash & Cash Equivalents | 2.62M |
| Total Debt | 378,000 |
| Net Cash | 2.24M |
| Net Cash Per Share | $0.33 |
| Equity (Book Value) | -10.32M |
| Book Value Per Share | -1.51 |
| Working Capital | -9.45M |
Cash Flow
| Operating Cash Flow | -10.46M |
| Capital Expenditures | n/a |
| Free Cash Flow | -10.46M |
| FCF Per Share | -$2.26 |
Margins
Gross margin is 59.73%, with operating and profit margins of -74.13% and -36.26%.
| Gross Margin | 59.73% |
| Operating Margin | -74.13% |
| Pretax Margin | -36.26% |
| Profit Margin | -36.26% |
| EBITDA Margin | -72.49% |
| EBIT Margin | -74.33% |
| FCF Margin | -48.65% |
Dividends & Yields
AGRX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -407.86% |
| Shareholder Yield | -407.86% |
| Earnings Yield | -80.62% |
| FCF Yield | -108.18% |
Analyst Forecast
The average price target for AGRX is $12.00, which is 751.06% higher than the current price. The consensus rating is "Buy".
| Price Target | $12.00 |
| Price Target Difference | 751.06% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on April 11, 2023. It was a reverse split with a ratio of 1:50.
| Last Split Date | Apr 11, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:50 |
Scores
AGRX has an Altman Z-Score of -49.96 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -49.96 |
| Piotroski F-Score | 2 |